Clinical Trial Update: Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations [Phase 1]

View source ↗

Summary

Phase 1 platform study exploring translational endpoints to inform use of novel combinations in metastatic castration-resistant prostate cancer; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Parker Institute for Cancer Immunotherapy | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-04-12